SCHEMBL10365151

SCHEMBL10365151

O=C(O)c1cncc(C(=O)O)c1-c1cccnc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 5/20 0.56
MKNK2 Q9HBH9 5/20 0.56
KMO O15229 2/20 0.53
ALDH1A1 P00352 4/20 0.50
CYP2A6 P11509 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
APP P05067 1/20 0.50
GAA P10253 1/20 0.50
HCAR3 P49019 1/20 0.50
HCAR2 Q8TDS4 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
DHODH Q02127 3/20 0.48
KDM4E B2RXH2 2/20 0.48
LMNA P02545 2/20 0.48
HTT P42858 2/20 0.48
GPR35 Q9HC97 1/20 0.48
CYP19A1 P11511 1/20 0.44
TP53 P04637 1/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28404845 0.89 KMO (0.57) MKNK1MKNK2KMOALDH1A1CYP2A6
SCHEMBL2811220 0.84 ALDH1A1 (0.48) MKNK1MKNK2ALDH1A1KDM4ELMNA
SCHEMBL30705023 0.81 MKNK1 (0.56) MKNK1MKNK2KMOALDH1A1CYP2A6
SCHEMBL10364611 0.81 MKNK1 (0.56) MKNK1MKNK2KMOALDH1A1CYP2A6
SCHEMBL28830427 0.81 KMO (0.53) MKNK1MKNK2KMOALDH1A1CYP2A6
SCHEMBL28558289 0.80 MKNK1 (0.50) MKNK1MKNK2KMOALDH1A1CYP2A6
SCHEMBL5145882 0.79 KDM4E (0.67) MKNK1MKNK2KMOALDH1A1CYP2A6
SCHEMBL18797731 0.78 DHODH (0.55) MKNK1MKNK2KMOALDH1A1APP
SCHEMBL28790988 0.78 HNF4A (0.56) MKNK1MKNK2KMOALDH1A1L3MBTL1
SCHEMBL27585150 0.78 MAPK1 (0.52) MKNK1MKNK2KMOALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0206747-B1 1,4-DIHYDROPYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CARDIOVASCULAR DISORDERS, AND A PROCESS FOR PRODUCING THE DERIVATIVES WARNER-LAMBERT COMPANY (US) 1990-10-31 EP disclosed
EP-0206747-A2 1,4-Dihydropyridine derivatives useful in the treatment of cardiovascular disorders, and a process for producing the derivatives WARNER-LAMBERT COMPANY (US) 1986-12-30 EP disclosed